After a decade of cultivating trust, collaboration, and shared vision, we are proud to announce the completion of our Asia-Pacific Clinical Advisory Board. Rather than build in isolation, we chose to build through partnership and alignment with the most eminent and respected leaders across the region.
We have assembled a world-class group of leading surgeons united by a common belief: that the future of surgery must include perioperative nutrition as a standard of care.
This board is more than a structure — it is a manifestation of our philosophy: that science must be rigorous, credibility must be earned, and access must be universal. Their presence signals not only validation, but momentum — toward a future where every surgical patient, everywhere, has the best possible chance at recovery.
Our board members will play a pivotal role in advancing science, education, and awareness across the region. Mend currently has four investigator-initiated, grant-funded randomized controlled trials underway, with additional studies in development alongside esteemed institutions globally.
The Asia-Pacific chapter of our story begins now — and it begins with strength, purpose, and a collective commitment to transforming surgical care.
“When you bring the right people together — those who care deeply about patients, evidence, and real change — you don’t just create a board. You create a movement. This is what we’ve built in the Asia-Pacific. A board of doers and intellect. And it’s only the beginning.”
Goran Petrovic
CEO
MEND Nutrition Asia-Pacific
